Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 2506.98 | 578 / 578 | 94% | 10.26 | 1090 / 1155 |
breast | 80% | 337.08 | 366 / 459 | 95% | 9.71 | 1062 / 1118 |
intestine | 77% | 776.46 | 745 / 966 | 91% | 6.38 | 478 / 527 |
kidney | 73% | 347.20 | 65 / 89 | 95% | 11.35 | 853 / 901 |
stomach | 73% | 311.60 | 263 / 359 | 92% | 7.67 | 263 / 286 |
thymus | 74% | 363.34 | 484 / 653 | 78% | 11.34 | 472 / 605 |
prostate | 79% | 347.47 | 194 / 245 | 67% | 3.06 | 334 / 502 |
liver | 86% | 341.57 | 195 / 226 | 57% | 3.17 | 230 / 406 |
bladder | 71% | 402.05 | 15 / 21 | 69% | 5.15 | 350 / 504 |
brain | 45% | 189.92 | 1185 / 2642 | 95% | 10.05 | 669 / 705 |
uterus | 54% | 169.96 | 92 / 170 | 81% | 6.38 | 373 / 459 |
esophagus | 54% | 185.93 | 775 / 1445 | 81% | 5.31 | 148 / 183 |
adrenal gland | 84% | 340.51 | 217 / 258 | 45% | 1.88 | 103 / 230 |
pancreas | 16% | 56.92 | 53 / 328 | 88% | 8.36 | 156 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 43.09 | 29 / 29 |
peripheral blood | 100% | 19193.90 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 8247.96 | 241 / 241 | 0% | 0 | 0 / 0 |
skin | 22% | 61.34 | 398 / 1809 | 76% | 9.27 | 361 / 472 |
adipose | 97% | 690.09 | 1164 / 1204 | 0% | 0 | 0 / 0 |
ovary | 17% | 56.21 | 31 / 180 | 77% | 4.56 | 329 / 430 |
tonsil | 0% | 0 | 0 / 0 | 89% | 11.06 | 40 / 45 |
blood vessel | 53% | 271.28 | 703 / 1335 | 0% | 0 | 0 / 0 |
heart | 44% | 149.04 | 381 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 20% | 1.23 | 16 / 80 |
muscle | 3% | 7.11 | 22 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071800 | Biological process | podosome assembly |
GO_0060326 | Biological process | cell chemotaxis |
GO_0006911 | Biological process | phagocytosis, engulfment |
GO_0097320 | Biological process | plasma membrane tubulation |
GO_0042995 | Cellular component | cell projection |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0002102 | Cellular component | podosome |
GO_0005938 | Cellular component | cell cortex |
GO_0005576 | Cellular component | extracellular region |
GO_0070161 | Cellular component | anchoring junction |
GO_0001891 | Cellular component | phagocytic cup |
GO_0005886 | Cellular component | plasma membrane |
GO_0034774 | Cellular component | secretory granule lumen |
GO_0005515 | Molecular function | protein binding |
GO_0005543 | Molecular function | phospholipid binding |
Gene name | BIN2 |
Protein name | Bridging integrator 2 Bridging integrator 2 (Breast cancer-associated protein 1) |
Synonyms | BRAP1 |
Description | FUNCTION: Promotes cell motility and migration, probably via its interaction with the cell membrane and with podosome proteins that mediate interaction with the cytoskeleton. Modulates membrane curvature and mediates membrane tubulation. Plays a role in podosome formation. Inhibits phagocytosis. . |
Accessions | S4R418 ENST00000544402.5 [Q9UBW5-3] ENST00000605423.1 Q9UBW5 S4R3J0 ENST00000452142.7 [Q9UBW5-2] ENST00000615107.6 [Q9UBW5-1] ENST00000604560.6 |